Skip to main content

Applera to Pay Genetic Technologies $11.2M as Part of Settlement

NEW YORK, Jan. 4 (GenomeWeb News) - A California court has formally dismissed the patent infringement suit between Genetic Technologies and Applera, GTG said today.

 

As reported by GenomeWeb News on Dec. 12, Applera agreed to settle the lawsuit over GTG's junk DNA gene-testing technologies on Dec. 9.

 

Under the settlement, Applera agreed to take a license to the GTG non-coding patents and will make payments in the form of cash, equipment, reagents and intellectual property. The payments will total approximately AU$15 million ($11.2 million), GTG said.

 

The Northern California District Court formally dismissed the lawsuit on Dec. 30.

 

GTG has favourably resolved six lawsuits involving its patents and does not have any other cases pending.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.